Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD1-T Cells Combined with Docetaxel in Second-line Advanced NSCLC
NCT03944980Phase 3Unknown
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Jun 2019
- Primary completion
- Jun 2021
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 3 trial of PD1-T cells in non-small cell lung cancer (NSCLC), sponsored by Tianjin Medical University Cancer Institute and Hospital. Status: unknown.
02
Drugs
PD1-T cells
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03944980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03944980.